Lefèvre J P, Rossi M, Kowalski A. "Method for the Synthesis of 5-(3-(2-(Trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)thiazol-2-amine" [P]. European Patent, EP 3362413 A1, 2024-03-03.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2012, 596, (5), 1022-1042.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2025, 531, (1), 8434-8444.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 5-(3-(2-(Trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)thiazol-2-amine Using HRMS and NMR". Chemosphere, 2017, 2173, 9215-9220.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2016, 2349, (7), 5070-5095.